LINC00152 mediates cell proliferation, thereby affecting MCL-1 expression and mitochondrial apoptosis pathways via MCL-1, and acts as a competitive endogenous RNA (ceRNA) of miR-125b, which may represent a novel molecular mechanism for reversing cell proliferation in ovarian cancer [76]. Here, MCL1 is linked to ovarian carcinoma.